This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's How Much a $1000 Investment in Cigna Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Cigna (CI) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $294.45, marking a +0.92% move from the previous day.
Cigna's (CI) Evernorth Acquires Bright.md Technology Platform
by Zacks Equity Research
Cigna's (CI) Evernorth arm acquires Bright.md, enhancing MDLIVE's virtual care capabilities.
Cigna's (CI) Evernorth Launches Value-Based Care Program
by Zacks Equity Research
Cigna's (CI) Evernorth arm introduces a measurement-based care program for its behavioral health network.
Why Cigna (CI) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cigna (CI) Unveils 2024 Expansion Plans, Eyes Membership Growth
by Zacks Equity Research
Cigna (CI) declares the availability of a varied set of health plans across new counties in 2024. It, thereby, places intensified focus on growing its Medicare business.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cigna (CI) Stock Moves -1.09%: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $284.41, marking a -1.09% move from the previous day.
Cigna (CI) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Cigna (CI) closed at $288.47 in the latest trading session, marking a -1.99% move from the prior day.
Cigna (CI) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $284.64, marking a -0.25% move from the previous day.
Here's Why Investors Should Retain Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.
Cigna (CI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $286.53, marking a +0.6% move from the previous day.
Cigna (CI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cigna (CI) closed the most recent trading day at $281.48, moving +0.07% from the previous trading session.
Cigna's (CI) Unit Brings New Plan for Globally Mobile Seniors
by Zacks Equity Research
The new product from Cigna's (CI) Cigna Healthcare unit is likely to face significant demand in the global market.
Cigna (CI) Unit to Offer ACA Plans in 350 Counties in 2024
by Zacks Equity Research
Cigna (CI) plans to expand coverage in 15 counties in North Carolina and reach an additional 200,000 ACA Marketplace clients.
5 HMO Stocks to Watch Amid Growing Premiums & Membership
by Debasmita Chatterjee
Expanding customer base, contract wins and a rapidly growing aging U.S. population will likely drive the performances of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry trends.
Cigna (CI) Eases Care Delivery With Prior Authorization Removal
by Zacks Equity Research
Cigna's (CI) branch, Cigna Healthcare, lifts the prior authorization requirement on 600-plus medical services, thereby easing administrative burdens and making way for simplified care delivery.
Cigna (CI) Unit Ties Up to Offer Digital Health Tool to Clients
by Zacks Equity Research
Cigna's (CI) division, Cigna Healthcare, teams up with Virgin Pulse to make an effective digital health solution available to its clients, who can now improve their well-being.
Cigna (CI) Q2 Earnings Beat on Strong U.S. Commercial Unit
by Zacks Equity Research
Cigna's (CI) Q2 results reflect solid premium rate hikes and a growing membership base across its U.S. Commercial and Medicare Advantage businesses.
Here's What Key Metrics Tell Us About Cigna (CI) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Cigna (CI) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Cigna (CI) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 2.51% and 3.16%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Radian (RDN) Tops Q2 Earnings Estimates
by Zacks Equity Research
Radian (RDN) delivered earnings and revenue surprises of 19.74% and 3.55%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Will High Medical Costs Hurt Cigna (CI) in Q2 Earnings?
by Zacks Equity Research
Cigna's (CI) Q2 results are likely to reflect strength in the specialty pharmacy business and growing medical customer base, partly offset by higher medical expenses.
Cigna (CI) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Cigna (CI) closed at $290.69 in the latest trading session, marking a -1.36% move from the prior day.
Cigna (CI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Cigna (CI) closed at $292.06 in the latest trading session, marking a -0.58% move from the prior day.